On October 2, 2018, ScienceDaily spotlighted the research of Christin Burd, Ph.D., James Kirkland, M.D, Ph.D., Laura Niedernhofer, M.D., Ph.D., and Ming Xu, Ph.D. on Fisetin, a senotherapeutic that extends health and lifespan. Their findings expands research published in July in Nature Medicine.
Dr. Burd is a 2014 AFAR Research Grant for Junior Faculty recipient.
Dr. Kirkland is the AFAR President-elect and 2012 Glenn/AFAR Breakthroughs in Gerontology Award recipient.
Dr. Niedernhofer is a Current National Scientific Advisory Council member, 2017 Pilot grantee, and 2018 Vincent Cristofalo awardee.
Dr. Xu is a 2014 Glenn/AFAR Postdoctoral Fellowship Program for Translational Research on Aging recipient and a 2017 Irene Diamond Fund/AFAR Postdoctoral Transition Awards in Aging fellow.
Read “Researchers have discovered how to slow aging” here and read a related press release here.
